The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP)
Condition(s):HIV InfectionsLast Updated:September 21, 2022Completed
Hide Studies Not Open or Pending
Condition(s):HIV InfectionsLast Updated:September 21, 2022Completed
Condition(s):ThalassemiaLast Updated:June 29, 2017Completed
Condition(s):BehçetLast Updated:January 6, 2020Completed
Condition(s):Drug Metabolism; Membrane TransportLast Updated:May 12, 2016Completed
Condition(s):Cerebral Small Vessel Diseases; Cognitive Impairment; StrokeLast Updated:January 19, 2018Completed
Condition(s):Postoperative PainLast Updated:December 27, 2017Completed
Condition(s):Coronavirus Disease-2019 (COVID-19) PreventionLast Updated:October 13, 2023Completed
Condition(s):Meningitis; Meningococcal InfectionLast Updated:April 14, 2016Completed
Condition(s):Norovirus PreventionLast Updated:August 21, 2017Completed
Condition(s):HIV InfectionsLast Updated:October 15, 2021Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.